Citizens Initiates Coverage On Biomea Fusion with Market Outperform Rating, Announces Price Target of $9

Benzinga Newsdesk www.benzinga.com Positive 74.3%

Neg 0% Neu 0% Pos 74.3%

Citizens analyst Jonathan Wolleben initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Market Outperform rating and announces Price Target of $9.